M S Mitchell

Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].

M S Mitchell, Raymond A. Kempf, W. Harel et al. · Journal of Clinical Oncology · 1988 · 197 citations

Low-dose Intravenous Interleukin-2, Low-dose Cyclophosphamide, Medicine +12

Active-specific immunotherapy for melanoma.

M S Mitchell, W. Harel, Raymond A. Kempf et al. · Journal of Clinical Oncology · 1990 · 184 citations

Active-specific Immunotherapy, Tumor Immunology, Surgical Oncology +15

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.

Hyman B. Muss, J J Costanzi, Richard D. Leavitt et al. · Journal of Clinical Oncology · 1987 · 165 citations

Surgical Oncology, Sc Dosage, Lung Metastases +17

Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes.

June Kan‐Mitchell, M S Mitchell, Nagesh Rao et al. · PubMed · 1989 · 134 citations

Pathology, Cell Proliferation, Dermatology +16

Sequence analysis of bacteriophage T4 DNA packaging/terminase genes 16 and 17 reveals a common ATPase center in the large subunit of viral terminases

M S Mitchell · Nucleic Acids Research · 2002 · 124 citations · Full text